Min joined CellCentric in August 2026. 

Min brings over a decade of experience leading biostatistics across medical devices, biologics, and drug development. Most recently, he held the Associate Director in Biostatistics role at Blueprint Medicines, which develops precision medicines targeting the genetic drivers of disease. His expertise spans early- and late-phase clinical development, regulatory submissions, and post-approval support. Throughout his career, Min has partnered closely with cross-functional teams to develop clinical and statistical strategies and has contributed to the successful approval of multiple therapies. 

Min holds an MS in Biostatistics from Columbia University and a PhD in Biology from the University of Kentucky.